| 1 |
15730714 | [Targeted blockage of STAT5 by a decoy oligodeoxynucleotide inhibits the growth and proliferation of K562 cells]. | 2004 Dec |
1 |
| 2 |
10565030 | Inhibition of c-ABL expression in hematopoietic progenitor cells using antisense oligodeoxynucleotides. | 2000 |
1 |
| 3 |
10414920 | Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia. | 1999 Jun |
2 |
| 4 |
9558370 | BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. | 1998 May 1 |
3 |
| 5 |
9558400 | Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. | 1998 May 1 |
1 |
| 6 |
9616172 | Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation. | 1998 Jun 15 |
2 |
| 7 |
10921025 | [Inhibition of apoptosis by bcr-abl fusion gene in K562 cells]. | 1998 Sep |
1 |
| 8 |
9305594 | Preclinical studies of streptolysin-O in enhancing antisense oligonucleotide uptake in harvests from chronic myeloid leukaemia patients. | 1997 Sep |
1 |
| 9 |
8597610 | Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells: uptake, biological effects and modulation of gene expression. | 1996 Feb |
2 |
| 10 |
8907275 | Liposomal delivery of oligodeoxynucleotides. | 1996 Mar |
1 |
| 11 |
7579358 | BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism. | 1995 Nov 15 |
1 |
| 12 |
7579442 | Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. | 1995 Nov 1 |
1 |
| 13 |
7606003 | Optimization of antisense oligodeoxynucleotide structure for targeting bcr-abl mRNA. | 1995 Jul 15 |
2 |
| 14 |
8535209 | Poor cellular uptake of antisense oligodeoxynucleotides: an obstacle to their use in chronic myeloid leukaemia. | 1995 Oct |
1 |
| 15 |
7701917 | Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells. | 1994 |
1 |
| 16 |
8026602 | Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment? | 1994 |
2 |
| 17 |
8118022 | BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. | 1994 Mar 1 |
1 |
| 18 |
1857987 | Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. | 1991 Aug 2 |
1 |
| 19 |
2672339 | Lineage-specific requirement of c-abl function in normal hematopoiesis. | 1989 Sep 8 |
1 |